The roles of hypoxia in the in vitro engineering of tissues

Tissue Engineering

Volumn 13, Issue 9, 2007, Pages 2153-2162

  Malda, Jos ^a   Klein, Travis J ^a   Upton, Zee ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOREACTORS; CELL GROWTH; GRAFTS; IMPLANTS (SURGICAL); OXYGEN; TISSUE ENGINEERING;

ANGIOGENESIS; CELL FUNCTIONS; OXYGEN CARRIERS; OXYGEN CHAMBERS; TISSUE THICKNESS;

MEDICAL PROBLEMS;

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; FLUOROCARBON; GLYCOSAMINOGLYCAN; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EPITHELIZATION; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; LIVER; MUSCLE CELL; OSTEOBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SKIN; TISSUE ENGINEERING; WOUND HEALING;

ANIMALS; ANOXIA; HUMANS; OXYGEN; TISSUE ENGINEERING; WOUND HEALING;

EID: 34548650403     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0417     Document Type: Article

References (111)

1. Levenberg, S., and Langer, R. Advances in tissue engineering. Curr Top Dev Biol 61, 113, 2004.
2. Lewis, M.C., Macarthur, B.D., Malda, J., Pettet, G., and Please, C.P. Heterogeneous proliferation within engineered cartilaginous tissue: the role of oxygen tension. Biotechnol Bioeng 91, 607, 2005.
3. Radisic, M., Malda, J., Epping, E., Geng, W., Langer, R., and Vunjak-Novakovic, G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 93, 332, 2006.
4. Malda, J., Rouwkema, J., Martens, D.E., Le Comte, E.P., Kooy, F.K., Tramper, J., Van Blitterswijk, C.A., and Riesle, J. Oxygen gradients in tissue-engineered Pegt/Pbt cartilaginous constructs: Measurement and modeling. Biotechnol Bioeng 86, 9, 2004.
5. Kellner, K., Liebsch, G., Klimant, I., Wolfbeis, O., Blunk, T., Schulz, M., and Gopferich, A. Determination of oxygen gradients in engineered tissue using a fluorescent sensor. Biotechnol Bioeng 80, 73, 2002.
6. Obradovic, B., Meldon, J., Freed, L., and Vunjak-Novakovic, G. Glycosaminoglycan deposition in engineered cartilage: experiments and mathematical model. AIChE J 46, 1860, 2000.
7. Malda, J., Woodfield, T.B., Van Der Vloodt, F., Kooy, F.K., Martens, D.E., Tramper, J., Blitterswijk, C.A., and Riesle, J. The effect of PEGT/PBT scaffold architecture on oxygen gradients in tissue engineered cartilaginous constructs. Biomaterials 25, 5773, 2004.
8. Priestley, J. Observations on different kinds of air. Philosophical Transactions 62, 147, 1772.
9. Lavoisier, A. Traité Elémentaire de Chimie. Présenté dans un Ordre Nouveau et d'aprés Découvertes Modernes. Paris: Cuchet, 1789.
10. Silver, I.A. Measurement of pH and ionic composition of pericellular sites. Philos Trans R Soc Lond B Biol Sci 271, 261, 1975.
11. Lee, R.B., and Urban, J.P.G. Evidence for a negative Pasteur effect in articular cartilage. Biochem J 321, 95, 1997.
12. Bassett, C., and Herrmann, I. Influence of oxygen concentration and mechanical factors on differentiation of connective tissues in vitro. Nature 190, 460, 1961.
13. Malda, J., Martens, D.E., Tramper, J., van Blitterswijk, C.A., and Riesle, J. Cartilage tissue engineering: controversy in the effect of oxygen. Crit Rev Biotechnol 23, 175, 2003.
14. Utting, J.C., Robins, S.P., Brandao-Burch, A., Orriss, I.R., Behar, J., and Arnett, T.R. Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp Cell Res 312, 1693, 2006.
15. D'Ippolito, G., Diabira, S., Howard, G.A., Roos, B.A.. and Schiller, P.C. Low oxygen tension inhibits osteogenic differentiation and enhances sternness of human MIAMI cells. Bone 39, 513, 2006.
16. Robins, J.C., Akeno, N., Mukherjee, A., Dalai, R.R., Aronow, B.J., Koopman, P., and Clemens, T.L. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 37, 313, 2005.
17. Malda, J., Van Blitterswijk, C.A., Van Geffen, M., Martens, D.E., Tramper, J., and Riesle, J. Low oxygen tension stimulates the redifferentiation of dedifferentiated adult human nasal chondrocytes. Osteoarthritis Cartilage 12, 306, 2004.
18. Mizuno, S., and Glowacki, J. Low oxygen tension enhances chondroinduction by demineralized bone matrix in human dermal fibroblasts in vitro. Cells Tissues Organs 180, 151, 2005.
19. Chen, L., Fink, T., Ebbesen, P., and Zachar, V. Optimized chondrogenesis of ATCD5 cells through sequential regulation of oxygen conditions. Tissue Eng 12, 559, 2006.
20. Hirao, M., Tamai, N., Tsumaki, N., Yoshikawa, H., and Myoui, A. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem 281, 31079, 2006.
21. Domm, C., Schunke, M., Christesen, K., and Kurz, B. Redifferentiation of dedifferentiated bovine articular chondrocytes in alginate culture under low oxygen tension. Osteoarthritis Cartilage 10, 13, 2002.
22. Saini, S., and Wick, T.M. Effect of low oxygen tension on tissue-engineered cartilage construct development in the concentric cylinder bioreactor. Tissue Eng 10, 825, 2004.
23. Murphy, C., and Sambanis, A. Effect of oxygen tension and alginate encapsulation on restoration of the differentiated phenotype of passaged chondrocytes. Tissue Eng 7, 791, 2001.
24. Murphy, C.L., and Polak, J.M. Control of human articular chondrocyte differentiation by reduced oxygen tension. J Cell Physiol 199, 451, 2004.
25. Wang, G.L., and Semenza, G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 90, 4304, 1993.
26. Wang, G.L., and Semenza, G.L. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270, 1230, 1995.
27. Jiang, B.H., Rue, E., Wang, G.L., Roe, R., and Semenza, G.L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271, 17771, 1996.
28. 2 tension. Proc Natl Acad Sci U S A 92, 5510, 1995.
29. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 95, 7987, 1998.
30. Manalo, D.J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B.D., Ye, S.Q., Garcia, J.G., and Semenza, G.L. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105, 659, 2005.
31. Kelly, B.D., Hackett, S.F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P.A., and Semenza, G.L. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93, 1074, 2003.
32. Reichner, J.S., and Albina, J.E. Determination of the role of hypoxia-inducible factor 1 in wound healing. Methods Enzymol 381, 527, 2004.
33. Kim, J.W., Tchernyshyov, I., Semenza, G.L., and Dang, C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metabolism 3, 177, 2006.
34. Schipani, E. Hypoxia and HIF-1 alpha in chondrogenesis. Ann N Y Acad Sci 1068, 66, 2006.
35. Schipani, E., Ryan, H., Didrickson, S., Kobayashi, T., Knight, M., and Johnson, R. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15, 2865, 2001.
36. Semenza, G.L., Shimoda, L.A., and Prabhakar, N.R. Regulation of gene expression by HIF-1. Novartis Found Symp 272, 2, 2006.
37. Zhao, L.L., Davidson, J.D., Wee, S.C., Roth, S.I., and Mustoe, T.A. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg 129, 1043, 1994.
38. De Jong, L., and Kemp, A. Stoicheiometry and kinetics of the prolyl 4-hydroxylase partial reaction. Biochim Biophys Acta 787, 105, 1984.
39. Knighton, D.R., Silver, I.A., and Hunt, T.K. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 90, 262, 1981.
40. LaVan, F.B., and Hunt, T.K. Oxygen and wound healing. Clin Plast Surg 17, 463, 1990.
41. Siddiqui, A., Galiano, R., Connors, D., Gruskin, E., Wu, L., and Mustoe, T. Differential effects of oxygen on human dermal fibroblasts: acute versus chronic hypoxia. Wound Repair Regen 4, 211, 1996.
42. O'Toole, E.A., Marinkovich, M.P., Peavey, C.L., Amieva, M.R., Furthmayr, H., Mustoe, T.A., and Woodley, D.T. Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest 100, 2881, 1997.
43. Tandara, A.A., and Mustoe, T.A. Oxygen in wound healing - more than a nutrient. World J Surg 28, 294, 2004.
44. Dery, M.A., Michaud, M.D., and Richard, D.E. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37, 535, 2005.
45. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12, 149, 1998.
46. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D., and Semenza, G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16, 4604, 1996.
47. Falanga, V., Qian, S.W., Danielpour, D., Katz, M.H., Roberts, A.B., and Sporn, M.B. Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. J Invest Dermatol 97, 634, 1991.
48. Kourembanas, S., Hannan, R.L., and Faller, D.V. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest 86, 670, 1990.
49. Hong, K.H., Yoo, S.A., Kang, S.S., Choi, J.J., Kim, W.U., and Cho, C.S. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts. Clin Exp Immunol 146, 362, 2006.
50. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843, 1992.
51. Cramer, T., Schipani, E., Johnson, R.S., Swoboda, B., and Pfander, D. Expression of VEGF isoforms by epiphyseal chondrocytes during low-oxygen tension is HIF-1 alpha dependent. Osteoarthritis Cartilage 12, 433, 2004.
52. Okuyama, H., Krishnamachary, B., Zhou, Y.F., Nagasawa, H., Bosch-Marce, M., and Semenza, G.L. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J Biol Chem 281, 15554, 2006.
53. Ferrara, N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25, 581, 2004.
54. Albina, J.E., Mastrofrancesco, B., Vessella, J.A., Louis, C.A., Henry, W.L., Jr., and Reichner, J.S. HIF-1 expression in healing wounds: HIF-1 alpha induction in primary inflammatory cells by TNF-alpha. Am J Physiol Cell Physiol 281, C1971, 2001.
55. Haroon, Z.A., Raleigh, J.A., Greenberg, C.S., and Dewhirst, M.W. Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann Surg 231, 137, 2000.
56. Thornton, R.D., Lane, P., Borghaei, R.C., Pease, E.A., Caro, J., and Mochan, E. Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem J 350 Pt 1, 307, 2000.
57. Bakker, D., and Cramer, F. Hyperbaric Surgery. Flagstaff, AZ: Best Publishing Company, 2002.
58. Kessler, L., Bilbault, P., Ortega, F., Grasso, C., Passemard, R., Stephan, D., Pinget, M., and Schneider, F. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes Care 26, 2378, 2003.
59. Faglia, E., Favales, F., Aldeghi, A., Calia, P., Quarantiello, A., Oriani, G., Michael, M., Campagnoli, P., and Morabito, A. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care 19, 1338, 1996.
60. Hammarlund, C., and Sundberg, T. Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. Plast Reconstr Surg 93, 829, 1994.
61. Roeckl-Wiedmann, I., Bennett, M., and Kranke, P. Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg 92, 24, 2005.
62. Kairuz, E., Dawson, R.A., Upton, Z., and Malda, J. Hyperbaric oxygen stimulates epidermal reconstruction in human skin equivalents. Wound Repair Regen 15, 266, 2007.
63. Carrier, R., Rupnick, M., Langer, R., Schoen, F., Freed, L., and Vunjak-Novakovic, G. Effects of oxygen on engineered cardiac muscle. Biotechnol Bioeng 78, 617, 2002.
64. Nieuwoudt, M.J., Moolman, S.F., Van Wyk, K.J., Kreft, E., Olivier, B., Laurens, J.B., Stegman, F.G., Vosloo, J., Bond, R., and van der Merwe, S.W. Hepatocyte function in a radial-flow bioreactor using a perfluorocarbon oxygen carrier. Artif Organs 29, 915, 2005.
65. Lee, S.H., Coger, R.N., and Clemens, M.G. Antioxidant functionality in hepatocytes using the enhanced collagen extracellular matrix under different oxygen tensions. Tissue Eng 2006 Sep 1; [Epub ahead of print].
66. Gordon, J.E., Dare, M.R., and Palmer, A.F. Engineering select physical properties of cross-linked red blood cells and a simple a priori estimation of their efficacy as an oxygen delivery vehicle within the context of a hepatic hollow fiber bioreactor. Biotechnol Prog 21, 1700, 2005.
67. Muschler, G.F., Nakamoto, C., and Griffith, L.G. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86-A, 1541, 2004.
68. Freed, L.E., Marquis, J.C., Vunjak-Novakovic, G., Emmanual, J., and Langer, R. Composition of cell-polymer cartilage implants. Biotech Bioeng 43, 605, 1994.
69. Wendt, D., Stroebel, S., Jakob, M., John, G.T., and Martin, I. Uniform tissues engineered by seeding and culturing cells in 3D scaffolds under perfusion at defined oxygen tensions. Biorheology 43, 481, 2006.
70. Dunn, J.C., Chan, W.Y., Cristini, V., Kim, J.S., Lowengrub, J., Singh, S., and Wu, B.M. Analysis of cell growth in three-dimensional scaffolds. Tissue Eng 12, 705, 2006.
71. Martin, I., Obradovic, B., Freed, L., and Vunjak-Novakovic, G. Method for quantitative analysis of glycosaminoglycan distribution in cultured natural and engineered cartilage. Ann Biomed Eng 27, 656, 1999.
72. Zhang, J., Hua, Z., Tame, J.R., Lu, G., Zhang, R., and Gu, X. The crystal structure of a high oxygen affinity species of haemoglobin (bar-headed goose haemoglobin in the oxy form). J Mol Biol 255, 484, 1996.
73. Kaihara, S., Borenstein, J., Koka, R., Lalan, S., Ochoa, E.R., Ravens, M., Pien, H., Cunningham, B., and Vacanti, J.P. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng 6, 105, 2000.
74. Sachlos, E., Reis, N., Ainsley, C., Derby, B., and Czernuszka, J.T. Novel collagen scaffolds with predefined internal morphology made by solid freeform fabrication. Biomaterials 24, 1487, 2003.
75. Fidkowski, C., Kaazempur-Mofrad, M.R., Borenstein, J., Vacanti, J.P., Langer, R., and Wang, Y. Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng 11, 302, 2005.
76. Zisch, A.H., Lutolf, M.P., and Hubbell, J.A. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 12, 295, 2003.
77. Zisch, A.H., Lutolf, M.P., Ehrbar, M., Raeber, G.P., Rizzi, S.C., Davies, N., Schmokel, H., Bezuidenhout, D., Djonov, V., Zilla, P., and Hubbell, J.A. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. Faseb J 17, 2260, 2003.
78. Laschke, M.W., Harder, Y., Amon, M., Martin, I., Farhadi, J., Ring, A., Torio-Padron, N., Schramm, R., Rucker, M., Junker, D., Haufel, J.M., Carvalho, C., Heberer, M., Germann, G., Vollmar, B., and Menger, M.D. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 12, 2093, 2006.
79. Leach, J.K., Kaigler, D., Wang, Z., Krebsbach, P.H., and Mooney, D.J. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 27, 3249, 2006.
80. Martin, I., Wendt, D., and Heberer, M. The role of bioreactors in tissue engineering. Trends Biotechnol 22, 80, 2004.
81. Obradovic, B., Carrier, R., Vunjak-Novakovic, G., and Freed, L. Gas exchange is essential for bioreactor cultivation of tissue engineered cartilage. Biotechnol Bioeng 63, 197, 1999.
82. Sikavitsas, V.I., Bancroft, G.N., Lemoine, J.J., Liebschner, M.A., Dauner, M., and Mikos, A.G. Flow perfusion enhances the calcified matrix deposition of marrow stromal cells in biodegradable nonwoven fiber mesh scaffolds. Ann Biomed Eng 33, 63, 2005.
83. Radisic, M., Deen, W., Langer, R., and Vunjak-Novakovic, G. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol 288, H1278, 2005.
84. Radisic, M., Park, H., Chen, F., Salazar-Lazzaro, J.E., Wang, Y., Dennis, R., Langer, R., Freed, L.E., and Vunjak-Novakovic, G. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng 12, 2077, 2006.
85. Khattak, S.F., Chin, K.S., Bhatia, S.R., and Roberts, S.C. Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol Bioeng 2006.
86. Levenberg, S., Rouwkema, J., Macdonald, M., Garfein, E.S., Kohane, D.S., Darland, D.C., Marini, R., van Blitterswijk, C.A., Mulligan, R.C., D'Amore, P.A., and Langer, R. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23, 879, 2005.
87. Black, A.F., Berthod, F., L'Heureux, N., Germain, L., and Auger, F.A. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. Faseb J 12, 1331, 1998.
88. Tremblay, P.L., Hudon, V., Berthod, F., Germain, L., and Auger, F.A. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transplant 5, 1002, 2005.
89. Rouwkema, J., de Boer, J., and Van Blitterswijk, C.A. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 12, 2685, 2006.
90. Franceschi, R.T. Biological approaches to bone regeneration by gene therapy. J Dent Res 84, 1093, 2005.
91. Trentin, D., Hall, H., Wechsler, S., and Hubbell, J.A. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1 alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A 103, 2506, 2006.
92. von Degenfeld, G., Banfi, A., Springer, M.L., and Blau, H.M. Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis. Br J Pharmacol 140, 620, 2003.
93. Patel, T.H., Kimura, H., Weiss, C.R., Semenza, G.L., and Hofmann, L.V. Constitutively active HIF-1 alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia. Cardiovasc Res 68, 144, 2005.
94. Duyndam, M., Verloop, R., Engelse, M., and van Hinsbergh, V. Improving tissue graft survival by vascularization support. Abstract presented at the Dutch Symposium on Tissue Engineering, Noorwijkerhout, The Netherlands, 2006. Abstract no. 54.
95. Suzuki, K., Murtuza, B., Smolenski, R.T., Sammut, I.A., Suzuki, N., Kaneda, Y., and Yacoub, M.H. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104, 1207, 2001.
96. Woodfield, T.B., Malda, J., De Wijn, J., Peters, F., Riesle, J., and Van Blitterswijk, C.A. Design of porous scaffolds for cartilage tissue engineering using a three-dimensional fiber-deposition technique. Biomaterials 25, 4149, 2004.
97. Malda, J., Woodfield, T.B., Van Der Vloodt, F., Wilson, C., Martens, D.E., Tramper, J., Van Blitterswijk, C.A., and Riesle, J. The effect of PEGT/PBT scaffold architecture on the composition of tissue engineered cartilage. Biomaterials 26, 63, 2005.
98. Sikavitsas, V.I., Bancroft, G.N., Holtorf, H.L., Jansen, J.A., and Mikos, A.G. Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci U S A 100, 14683, 2003.
99. Janssen, F.W., Hofland, I., van Oorschot, A., Oostra, J., Peters, H., and van Blitterswijk, C.A. Online measurement of oxygen consumption by goat bone marrow stromal cells in a combined cell-seeding and proliferation perfusion bioreactor. J Biomed Mater Res A 79, 338, 2006.
100. Martin, Y., and Vermette, P. Bioreactors for tissue mass culture: design, characterization, and recent advances. Biomaterials 26, 7481, 2005.
101. Li, K.W., Klein, T.J., Chawla, K., Nugent, G.E., Bae, W.C., and Sah, R.L. In vitro physical stimulation of tissue-engineered and native cartilage. In: Sabatini, M., DeCeuninck, F., and Pastoureau, P., eds. Cartilage and Osteoarthritis, Totowa, NJ: Humana Press, 2004, pp. 325-352.
102. Vandegriff, K.D. Haemoglobin-based oxygen carriers. Expert Opin Investig Drugs 9, 1967, 2000.
103. Lee, R.B., and Urban, J.P. Functional replacement of oxygen by other oxidants in articular cartilage. Arthritis Rheum 46, 3190, 2002.
104. Dimitrijevich, S.D., Paranjape, S., Wilson, J.R., Gracy, R.W., and Mills, J.G. Effect of hyperbaric oxygen on human skin cells in culture and in human dermal and skin equivalents. Wound Repair Regen 7, 53, 1999.
105. Netzlaff, F., Lehr, C.M., Wertz, P.W., and Schaefer, U.F. The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm 60, 167, 2005.
106. Ponec, M. Skin constructs for replacement of skin tissues for in vitro testing. Adv Drug Deliv Rev 54, S19, 2002.
107. Medalie, D.A., Eming, S.A., Tompkins, R.G., Yarmush, M.L., Krueger, G.G., and Morgan, J.R. Evaluation of human skin reconstituted from composite grafts of cultured keratinocytes and human acellular dermis transplanted to athymic mice. J Invest Dermatol 107, 121, 1996.
108. Kroon, M.E., Koolwijk, P., van der Vecht, B., and van Hinsbergh, V.W. Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: involvement of at least two signal transduction pathways. J Cell Sci 114, 825, 2001.
109. Mao, X., Zeng, Q., Wang, X., Cao, L., and Bai, Z. Angiogenic potency of bone marrow stromal cells improved by ex vivo hypoxia prestimulation. J Huazhong Univ Sci Technol Med Sci 24, 566, 2004.
110. Li, T.S., Hamano, K., Suzuki, K., Ito, H., Zempo, N., and Matsuzaki, M. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am J Physiol Heart Circ Physiol 283, H468, 2002.
111. Wilhide, M.E., and Jones, W.K. Potential therapeutic gene for the treatment of ischemic disease: Ad2/hypoxia-inducible factor-1 alpha (HIF-1)/VP16 enhances B-type natriuretic peptide gene expression via a HIF-1-responsive element. Mol Pharmacol 69, 1773, 2006.